1. Home
  2. TGLS vs ATRC Comparison

TGLS vs ATRC Comparison

Compare TGLS & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tecnoglass Inc.

TGLS

Tecnoglass Inc.

HOLD

Current Price

$39.45

Market Cap

1.8B

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$28.39

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGLS
ATRC
Founded
1984
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.4B
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
TGLS
ATRC
Price
$39.45
$28.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$63.33
$51.17
AVG Volume (30 Days)
309.6K
830.1K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
1.41%
N/A
EPS Growth
N/A
74.74
EPS
0.71
N/A
Revenue
$370,984,000.00
$201,630,000.00
Revenue This Year
$13.56
$15.27
Revenue Next Year
$9.04
$12.21
P/E Ratio
$54.41
N/A
Revenue Growth
17.98
15.40
52 Week Low
$37.52
$25.52
52 Week High
$90.34
$43.18

Technical Indicators

Market Signals
Indicator
TGLS
ATRC
Relative Strength Index (RSI) 42.36 50.92
Support Level N/A $26.47
Resistance Level $46.89 $30.75
Average True Range (ATR) 2.05 1.46
MACD -0.28 0.10
Stochastic Oscillator 20.29 69.26

Price Performance

Historical Comparison
TGLS
ATRC

About TGLS Tecnoglass Inc.

Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: